@article{park_grimes_wallace_sterman_mankin_campbell_flannery_milovancev_mathews_schmiedt_2018, title={Lung lobe torsion in dogs: 52 cases (2005-2017)}, volume={47}, ISSN={["1532-950X"]}, DOI={10.1111/vsu.13108}, abstractNote={OBJECTIVE
To report outcomes and risk factors for mortality in dogs that underwent surgical management of lung lobe torsion.


STUDY DESIGN
Retrospective case series from 5 veterinary teaching hospitals (2005-2017).


ANIMALS
Fifty dogs with 52 instances of lung lobe torsion.


METHODS
Data collected from medical records included signalment, clinical findings, results of clinicopathologic testing and diagnostic imaging, surgical treatment, lung lobe affected, intraoperative and postoperative complications, histopathologic and microbiologic findings, and outcome. Follow-up was obtained from medical records and telephone contact with primary care veterinarians.


RESULTS
Fifty-two instances of lung lobe torsion were identified in 50 dogs, with a median follow-up of 453 days (range, 0-3075). Forty-six (92%) dogs survived to discharge. Dogs with concurrent torsion of the right cranial and middle lung lobes were less likely to survive (2/4) than those with torsion of the left cranial lung lobe (22/22). No other risk factors for mortality prior to hospital discharge were identified. Overall median survival time after hospital discharge was 1369 days. Four dogs had >1 episode of lung lobe torsion.


CONCLUSION
The percentage of dogs surviving to discharge after surgical treatment of lung lobe torsion was higher than previously reported. The short- and long-term prognosis was excellent with surgical treatment of lung lobe torsion.


CLINICAL SIGNIFICANCE
Surgery should be recommended when lung lobe torsion is suspected because of the high survival to discharge rate and excellent long-term prognosis.}, number={8}, journal={VETERINARY SURGERY}, author={Park, Karen M. and Grimes, Janet A. and Wallace, Mandy L. and Sterman, Allyson A. and Mankin, Kelley M. Thieman and Campbell, Bonnie G. and Flannery, Erin E. and Milovancev, Milan and Mathews, Kyle G. and Schmiedt, Chad W.}, year={2018}, month={Nov}, pages={1002–1008} }
 @article{hegarty_qurollo_thomas_park_chandrashekar_beall_thatcher_breitschwerdt_2015, title={Serological and molecular analysis of feline vector-borne anaplasmosis and ehrlichiosis using species-specific peptides and PCR}, volume={8}, ISSN={1756-3305}, url={http://dx.doi.org/10.1186/s13071-015-0929-8}, DOI={10.1186/s13071-015-0929-8}, abstractNote={With the exception of Bartonella spp. or Cytauxzoon felis, feline vector-borne pathogens (FVBP) have been less frequently studied in North America and are generally under-appreciated as a clinical entity in cats, as compared to dogs or people. This study investigated selected FVBP seroreactivity and PCR prevalence in cats using archived samples. Feline blood samples submitted to the Vector Borne Diseases Diagnostic Laboratory (VBDDL) at North Carolina State University College of Veterinary Medicine (NCSU-CVM) between 2008 and 2013 were tested using serological assays and PCR. An experimental SNAP® Multi-Analyte Assay (SNAP® M-A) (IDEXX Laboratories, Inc. Westbrook, Maine, USA) was used to screen all sera for antibodies to Anaplasma and Ehrlichia genus peptides and A.phagocytophilum, A.platys, B.burgdorferi, E.canis, E.chaffeensis, and E.ewingii species-specific peptides. PCR assays were used to amplify Anaplasma or Ehrlichia DNA from extracted ethylenediaminetetraacetic acid (EDTA)-anti-coagulated blood samples. Amplicons were sequenced to identify species. Overall, 7.8 % (56/715) of cats were FVBP seroreactive and 3.2 % (13/406) contained Anaplasma or Ehrlichia DNA. Serologically, B.burgdorferi (5.5 %) was the most prevalent FVBP followed by A.phagocytophilum (1.8 %). Ehrlichia spp. antibodies were found in 0.14 % (12/715) of cats with species-specific seroreactivity to E.canis (n = 5), E.ewingii (n = 2) and E.chaffeensis (n = 1). Of seropositive cats, 16 % (9/56) were exposed to more than one FVBP, all of which were exposed to B.burgdorferi and either A.phagocytophilum (n = 7) or E.ewingii (n = 2). Based upon PCR and DNA sequencing, 4, 3, 3, 2, and 1 cat were infected with A.phagocytophilum, A.platys, E. ewingii, E. chaffeensis and E.canis, respectively. Cats are exposed to and can be infected with vector-borne pathogens that commonly infect dogs and humans. To our knowledge, this study provides the first evidence for E.chaffeensis and E.ewingii infection in naturally-exposed cats in North America. Results from this study support the need for regional, serological and molecular FVBP prevalence studies, the need to further optimize serodiagnostic and PCR testing for cats, and the need for prospective studies to better characterize clinicopathological disease manifestations in cats infected with FVBP.}, number={1}, journal={Parasites & Vectors}, publisher={Springer Science and Business Media LLC}, author={Hegarty, Barbara C. and Qurollo, Barbara A. and Thomas, Brittany and Park, Karen and Chandrashekar, Ramaswamy and Beall, Melissa J. and Thatcher, Brendon and Breitschwerdt, Edward B.}, year={2015}, month={Jun}, pages={320} }